Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mehala Subramaniapillai

Biographic Data

ID7955768
NAMEMehala Subramaniapillai
GIVEN NAMESMehala
FAMILY NAMESubramaniapillai
SIGNATURESUBRAMANIAPILLAI M
AFFILIATIONSToronto Western Hospital
ORCID0000-0002-6917-3984
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Fatigue and cognitive impairment in Post-Covid-19 Syndrome

    Open Access•Felicia Ceban, Susan Ling et al.•ARTICLE•Brain, Behavior, and Immunity•2022

  • The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder

    Open Access•Roger S McIntyre, Mehala Subramaniapillai et al.•ARTICLE•Frontiers in Psychiatry•2020

    ClinicalTrials.gov, identifier NCT03053362

  • The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder

    Open Access•Bing Cao, Caroline Park et al.•ARTICLE•Frontiers in Psychiatry•2019

    Background: Anhedonia is a common, persistent, and disabling phenomenon in treated adults with Major Depressive Disorder (MDD). Hitherto, relatively few antidepressant agents have been evaluated with respect to their effect on anhedonia in MDD. Methods: This is a post-hoc analysis of a primary study that sought to evaluate the sensitivity to change of the THINC-integrated tool (THINC-it) in MDD (ClinicalTrials.gov Identifier: NCT03053362). Adults…

No prominent works on this page.

  • The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder

    Open Access•Bing Cao, Caroline Park et al.•ARTICLE•Frontiers in Psychiatry•2019

    Background: Anhedonia is a common, persistent, and disabling phenomenon in treated adults with Major Depressive Disorder (MDD). Hitherto, relatively few antidepressant agents have been evaluated with respect to their effect on anhedonia in MDD. Methods: This is a post-hoc analysis of a primary study that sought to evaluate the sensitivity to change of the THINC-integrated tool (THINC-it) in MDD (ClinicalTrials.gov Identifier: NCT03053362). Adults…

  • The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder

    Open Access•Roger S McIntyre, Mehala Subramaniapillai et al.•ARTICLE•Frontiers in Psychiatry•2020

    ClinicalTrials.gov, identifier NCT03053362

  • Fatigue and cognitive impairment in Post-Covid-19 Syndrome

    Open Access•Felicia Ceban, Susan Ling et al.•ARTICLE•Brain, Behavior, and Immunity•2022

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 works) · Major depressive disorder (2 works) · Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Treatment of Major Depression (2 works) · Vortioxetine (2 works) · Agomelatine (1 works) · Anhedonia (1 works) · Antidepressant (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae